About the Women’s Guild Lung Institute
For more than 60 years, Women's Guild has been supporting pioneering research and care at Cedars-Sinai. Its members, who share a powerful commitment to innovation and education, have raised more than $40 million to fund critical work in a variety of medical areas. That includes $20 million for the creation of a world-class research and treatment center for lung diseases.
History
Founded in 2012, the Women's Guild Lung Institute now provides comprehensive inpatient and outpatient care at Cedars-Sinai for diseases of the esophagus, chest, lungs and airways.
Led by Director Paul Noble, MD, the Women's Guild Lung Institute has made significant strides in the treatment of pulmonary illness. Its achievements include:
- Advancement of research in genetic links to lung cancer
- Establishment of a repository of biomarkers (characteristics that can indicate disease or disease risk) to facilitate ongoing research
- Doubling the number of lung transplants performed at Cedars-Sinai
- Development of the first medications approved by the U.S. Food and Drug Administration to treat idiopathic pulmonary fibrosis
- Development of novel therapeutics for the treatment of patients with COVID-19
Key Leaders
Paul Noble, MD
Zab Mosenifar, MD
Peter Chen, MD
William Parks, PhD
Karen Reckamp, MD